EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

PSG and Other Candidate Genes as Potential Biomarkers of Therapy Resistance in B-ALL: Insights from Chromosomal Microarray Analysis and Machine Learning

Valeriya Surimova iD, Natalya Risinskaya iD, Ekaterina Kotova, Abdulpatakh Abdulpatakhov, Anastasia Vasileva, Yulia Chabaeva iD, Sofia Starchenko, Olga Aleshina iD, Nikolay Kapranov, Irina Galtseva, Alina Ponomareva, Ilya Kanivets und 4 weitere

International Journal of Molecular Sciences · 2025

DOI: 10.3390/ijms26157437 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Valeriya Surimova und 15 weiteren Autor:innen. Beteiligte Einrichtung: National Medical Research Center for Hematology, 125167 Moscow, Russia. Hauptthemen laut MEDLINE: Machine Learning, Drug Resistance, Neoplasm, Biomarkers, Tumor, Precursor B-Cell Lymphoblastic Leukemia-Lymphoma. Die Arbeit nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Russian Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chromosomal microarray analysis (CMA) was performed for 40 patients with B-ALL undergoing treatment according to the ALL-2016 protocol to investigate the copy number alterations (CNAs) and copy neutral loss of heterozygosity (cnLOH) associated with minimal residual disease (MRD)-positive remission. Aberrations involving over 20,000 genes were identified, and a random forest approach was applied to isolate a subset of genes whose CNAs and cnLOH are significantly associated with poor therapeutic response. We have assembled the triple matched healthy population data and used that data as a reference, but not as a matched control. We identified a recurrent cluster of cnLOH in the 19q13.2–19q13.31 region, significantly enriched in MRD-positive patients (70% vs. 47% in the reference group vs. 16% in MRD-negative patients). This region includes the pregnancy-specific glycoprotein (PSG) gene family and the oncogene ERF, suggesting a potential role in leukemic persistence and treatment resistance. Additionally, we observed significant deletions involving 7p22.3 and 16q13, often as part of large-scale losses affecting almost the entire chromosomes 7 and 16, indicative of global chromosomal instability. These findings highlight specific genomic regions potentially involved in therapy resistance and may contribute to improved risk stratification in B-ALL. Our findings emphasize the value of high-resolution CMA in diagnostics and risk stratification and suggest that PSG genes and other candidate genes could serve as biomarkers for predicting treatment outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Machine LearningDrug Resistance, NeoplasmBiomarkers, TumorPrecursor B-Cell Lymphoblastic Leukemia-LymphomaHumansFemaleMaleDNA Copy Number VariationsLoss of HeterozygosityAdultNeoplasm, ResidualChildChromosome AberrationsAdolescentMicroarray AnalysisChild, PreschoolYoung Adult

Stichwörter der Autor:innen

acute B-lymphoblastic leukemia (B-ALL)copy neutral loss of heterozygosity (cnLOH)copy number alterations (CNAs)genesmachine learning

Substanzen

Biomarkers, Tumor

Autor:innen und Institutionen

  • National Medical Research Center for Hematology, 125167 Moscow, Russia.
  • Intelligent Systems in Management and Automation Department, Moscow Technical University of Communications and Informatics, 111024 Moscow, Russia.
  • "Genomed" Laboratory of Molecular Pathology, 115419 Moscow, Russia.

ORCID-Profile: Valeriya Surimova, Natalya Risinskaya, Yulia Chabaeva, Olga Aleshina, Sergey Kulikov, Andrey Sudarikov

Förderung

  • Russian Science Foundation

Zitieren

APA

Surimova, V., Risinskaya, N., Kotova, E., Abdulpatakhov, A., Vasileva, A., Chabaeva, Y., Starchenko, S., Aleshina, O., Kapranov, N., Galtseva, I., Ponomareva, A., Kanivets, I., Korostelev, S., Kulikov, S., Sudarikov, A., & Parovichnikova, E. (2025). PSG and Other Candidate Genes as Potential Biomarkers of Therapy Resistance in B-ALL: Insights from Chromosomal Microarray Analysis and Machine Learning. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26157437

Vancouver

Surimova V, Risinskaya N, Kotova E, Abdulpatakhov A, Vasileva A, Chabaeva Y, et al. PSG and Other Candidate Genes as Potential Biomarkers of Therapy Resistance in B-ALL: Insights from Chromosomal Microarray Analysis and Machine Learning. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26157437

BibTeX
@article{Surimova2025,
  author = {Surimova, Valeriya and Risinskaya, Natalya and Kotova, Ekaterina and Abdulpatakhov, Abdulpatakh and Vasileva, Anastasia and Chabaeva, Yulia and Starchenko, Sofia and Aleshina, Olga and Kapranov, Nikolay and Galtseva, Irina and Ponomareva, Alina and Kanivets, Ilya and Korostelev, Sergey and Kulikov, Sergey and Sudarikov, Andrey and Parovichnikova, Elena},
  title = {PSG and Other Candidate Genes as Potential Biomarkers of Therapy Resistance in B-ALL: Insights from Chromosomal Microarray Analysis and Machine Learning},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  doi = {10.3390/ijms26157437}
}
Kostenlos starten →